Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Natural History, Non-Interventional, Two-Part Study in Subjects With Fibrodysplasia Ossificans Progressiva (FOP)

NCT02322255 is registered in ClinicalTrials.gov with Clementia Pharmaceuticals Inc. as lead sponsor.

NCT NCT02322255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02322255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Natural History, Non-Interventional, Two-Part Study in Subjects With Fibrodysplasia Ossificans Progressiva (FOP)
Lead sponsor
Clementia Pharmaceuticals Inc.
Phase
Observational
Overall status
Completed
Start date
December 18, 2014
Completion date
April 9, 2020
Enrollment
114 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

fibrodysplasia ossificans progressiva